Takeda Pharmaceutical Co Ltd 20-F for FY2022
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2022-06-29
For: 2022-03-31
View Original
Added on
April 07, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 29, 2022, covering the fiscal year ended March 31, 2022 (FY2022).
Headline figures
Fiscal year ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 3.57T JPY
- up 11.6% from 3.2T JPY a year earlier
- Net income
- 230.06B JPY
- down 38.8% from net income of 376.01B JPY a year earlier
- Diluted EPS
- 145.87 JPY
- down 39.0% from 238.96 JPY a year earlier